September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
The addition of pembrolizumab to neoadjuvant chemotherapy in the phase III KEYNOTE-756 – European Society for Medical Oncology
Jan 29, 2025, 18:07

The addition of pembrolizumab to neoadjuvant chemotherapy in the phase III KEYNOTE-756 – European Society for Medical Oncology

ESMO – European Society for Medical Oncology shared a post on LinkedIn:

“The addition of pembrolizumab to neoadjuvant chemotherapy in the phase III KEYNOTE-756 significantly improves the pathological complete response rate in patients with high-risk, early-stage ER+/HER2− Breast Cancer.

Read the full news on ESMO Daily Reporter.”

pembrolizumab